US Stock MarketDetailed Quotes
GPCR Structure Therapeutics
- 34.170
- -3.520-9.34%
Close Nov 15 16:00 ET
- 34.170
- 0.0000.00%
Post 20:01 ET
1.96BMarket Cap-17695P/E (TTM)
37.760High33.920Low1.08MVolume37.750Open37.690Pre Close37.48MTurnover1.99%Turnover RatioLossP/E (Static)57.26MShares66.38052wk High2.18P/B1.85BFloat Cap26.61052wk Low--Dividend TTM54.12MShs Float75.017Historical High--Div YieldTTM10.19%Amplitude20.800Historical Low34.771Avg Price1Lot Size
Structure Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -56.23%-26.39M | -67.82%-34.08M | -72.35%-79.49M | -80.68%-21.73M | -96.14%-20.56M | -67.35%-16.89M | -50.23%-20.31M | -43.41%-46.12M | -11.78%-12.03M | -10.48M |
| Net income from continuing operations | -11.83%-26.03M | -44.85%-26.04M | -74.63%-89.62M | -106.34%-24.5M | -92.17%-23.86M | -66.91%-23.28M | -37.41%-17.98M | -34.88%-51.32M | 11.09%-11.88M | ---12.42M |
| Depreciation and amortization | 213.51%232K | 217.14%222K | 6.50%295K | 0.00%72K | 3.95%79K | 25.42%74K | 0.00%70K | 284.72%277K | 9.09%72K | --76K |
| Other non cash items | 389.77%431K | 421.43%438K | 88.76%655K | 172.37%207K | 196.77%276K | -8.33%88K | 2.44%84K | 43.98%347K | 16.92%76K | --93K |
| Change In working capital | -132.99%-2.03M | -74.82%-8.17M | 134.70%6.97M | 712.84%2.72M | 94.01%2.75M | 93.59%6.17M | -292.11%-4.67M | -26.93%2.97M | -129.11%-444K | --1.42M |
| -Change in prepaid assets | 45.30%2.41M | -117.60%-6.63M | -1,223.61%-4.04M | -654.31%-1.75M | -198.15%-900K | 285.67%1.66M | -3,039.18%-3.05M | 69.74%-305K | -154.95%-232K | --917K |
| -Change in payables and accrued expense | -148.94%-2.21M | 17.79%-1.22M | 205.98%11.3M | 6,789.71%4.55M | 413.14%3.71M | 11.21%4.52M | -43.91%-1.48M | -30.43%3.69M | -103.97%-68K | --723K |
| -Change in other current assets | -2,296.30%-1.78M | 96.61%-2K | 125.00%15K | 88.33%-7K | --0 | --81K | ---59K | -66.67%-60K | ---60K | --0 |
| -Change in other current liabilities | -374.74%-451K | -256.52%-328K | 12.74%-315K | 15.48%-71K | 43.00%-57K | 7.77%-95K | -24.32%-92K | -76.96%-361K | -33.33%-84K | ---100K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -56.23%-26.39M | -67.82%-34.08M | -72.35%-79.49M | -80.68%-21.73M | -96.14%-20.56M | -67.35%-16.89M | -50.23%-20.31M | -43.41%-46.12M | -11.78%-12.03M | ---10.48M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -197.65%-204.52M | 102.89%1.42M | -332.06%-268.34M | -1,847.84%-180.74M | 280.88%30.13M | -327.47%-68.71M | -23.41%-49.02M | -447.77%-62.11M | 857.50%10.34M | -16.66M |
| Net PPE purchase and sale | -123.56%-427K | ---162K | -1,298.06%-2.17M | -1,528.17%-1.16M | -1,038.89%-820K | -460.38%-191K | --0 | 87.15%-155K | 40.83%-71K | ---72K |
| Net investment purchase and sale | -197.85%-204.09M | 103.22%1.58M | -329.64%-266.18M | -1,824.82%-179.59M | 286.61%30.95M | -324.88%-68.52M | -23.61%-49.02M | -424.96%-61.95M | 767.67%10.41M | ---16.59M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -197.65%-204.52M | 102.89%1.42M | -332.06%-268.34M | -1,847.84%-180.74M | 280.88%30.13M | -327.47%-68.71M | -23.41%-49.02M | -447.77%-62.11M | 857.50%10.34M | ---16.66M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 173,400.67%514.7M | -99.59%702K | 1,456.25%451.53M | 89,223.10%281.63M | 282.63%473K | -100.96%-297K | 11,821.41%169.73M | -71.90%29.01M | -174.78%-316K | -259K |
| Net common stock issuance | --514.57M | --0 | --472.3M | --300M | --0 | --0 | --172.3M | --0 | --0 | --0 |
| Net preferred stock issuance | ---- | ---- | --0 | --0 | ---- | ---- | ---- | -69.52%31.5M | --0 | --0 |
| Proceeds from stock option exercised by employees | 301.68%719K | 2,335.48%755K | 2,324.24%800K | --117K | 1,531.03%473K | 4,375.00%179K | --31K | 200.00%33K | --0 | --29K |
| Net other financing activities | -23.74%-589K | 97.96%-53K | -756.09%-21.57M | -5,750.63%-18.49M | --0 | -1.93%-476K | -79.63%-2.6M | -2,090.43%-2.52M | ---316K | ---288K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 173,400.67%514.7M | -99.59%702K | 1,456.25%451.53M | 89,223.10%281.63M | 282.63%473K | -100.96%-297K | 11,821.41%169.73M | -71.90%29.01M | -174.78%-316K | ---259K |
| Net cash flow | ||||||||||
| Beginning cash position | -22.66%97.83M | 397.46%129.79M | -75.22%26.09M | 80.25%50.64M | -26.85%40.59M | 149.88%126.49M | -75.22%26.09M | 543.99%105.31M | -75.59%28.09M | --55.49M |
| Current changes in cash | 430.37%283.8M | -131.83%-31.96M | 230.91%103.7M | 4,055.82%79.16M | 136.66%10.05M | -1,864.63%-85.9M | 283.60%100.4M | -189.05%-79.21M | 79.57%-2M | ---27.4M |
| End cash Position | 840.18%381.63M | -22.66%97.83M | 397.46%129.79M | 397.46%129.79M | 80.25%50.64M | -26.85%40.59M | 149.88%126.49M | -75.22%26.09M | -75.22%26.09M | --28.09M |
| Free cash flow | -56.98%-26.82M | -68.61%-34.24M | -76.46%-81.66M | -89.18%-22.89M | -102.57%-21.38M | -70.14%-17.09M | -49.51%-20.31M | -38.69%-46.28M | -11.20%-12.1M | ---10.55M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
